285 related articles for article (PubMed ID: 15350255)
1. Aromatase inhibition reduces the dose of gonadotropin required for controlled ovarian hyperstimulation.
Mitwally MF; Casper RF
J Soc Gynecol Investig; 2004 Sep; 11(6):406-15. PubMed ID: 15350255
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of aromatase inhibitor co-treatment for controlled ovarian stimulation.
Bedaiwy MA; Forman R; Mousa NA; Al Inany HG; Casper RF
Hum Reprod; 2006 Nov; 21(11):2838-44. PubMed ID: 16877370
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
4. Letrozole co-treatment in infertile women 40 years old and older receiving controlled ovarian stimulation and intrauterine insemination.
Bedaiwy MA; Shokry M; Mousa N; Claessens A; Esfandiari N; Gotleib L; Casper R
Fertil Steril; 2009 Jun; 91(6):2501-7. PubMed ID: 18501899
[TBL] [Abstract][Full Text] [Related]
5. Randomized controlled trial comparing superovulation with letrozole versus recombinant follicle-stimulating hormone combined with intrauterine insemination for couples with unexplained infertility who had failed clomiphene citrate stimulation and intrauterine insemination.
Gregoriou O; Vlahos NF; Konidaris S; Papadias K; Botsis D; Creatsas GK
Fertil Steril; 2008 Sep; 90(3):678-83. PubMed ID: 17961561
[TBL] [Abstract][Full Text] [Related]
6. Follicular phase dynamics with combined aromatase inhibitor and follicle stimulating hormone treatment.
Bedaiwy MA; Mousa NA; Esfandiari N; Forman R; Casper RF
J Clin Endocrinol Metab; 2007 Mar; 92(3):825-33. PubMed ID: 17192292
[TBL] [Abstract][Full Text] [Related]
7. A randomized controlled trial evaluating metformin pre-treatment and co-administration in non-obese insulin-resistant women with polycystic ovary syndrome treated with controlled ovarian stimulation plus timed intercourse or intrauterine insemination.
Palomba S; Falbo A; Orio F; Manguso F; Russo T; Tolino A; Annamaria C; Dale B; Zullo F
Hum Reprod; 2005 Oct; 20(10):2879-86. PubMed ID: 15958399
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of combined metformin-letrozole in comparison with metformin-clomiphene citrate in clomiphene-resistant infertile women with polycystic ovarian disease.
Sohrabvand F; Ansari Sh; Bagheri M
Hum Reprod; 2006 Jun; 21(6):1432-5. PubMed ID: 16478764
[TBL] [Abstract][Full Text] [Related]
9. A randomized single-blind controlled trial of letrozole as a low-cost IVF protocol in women with poor ovarian response: a preliminary report.
Goswami SK; Das T; Chattopadhyay R; Sawhney V; Kumar J; Chaudhury K; Chakravarty BN; Kabir SN
Hum Reprod; 2004 Sep; 19(9):2031-5. PubMed ID: 15217999
[TBL] [Abstract][Full Text] [Related]
10. Comparison of daily and alternate day recombinant follicle-stimulating hormone stimulation protocols for intrauterine insemination.
Kabli N; Sylvestre C; Tulandi T; Buckett W
Fertil Steril; 2009 Apr; 91(4):1141-4. PubMed ID: 18342857
[TBL] [Abstract][Full Text] [Related]
11. Ovulation induction with low doses of "pure" follicle stimulating hormone using a fixed protocol in patients with polycystic ovarian disease.
Bregieiro LO; de Moura MD; Ferriani RA; Bailão LA; de Sá MF
Int J Fertil Menopausal Stud; 1993; 38(3):152-9. PubMed ID: 8348163
[TBL] [Abstract][Full Text] [Related]
12. Hormonal profile and endometrial morphology in letrozole-controlled ovarian hyperstimulation in ovulatory infertile patients.
Cortínez A; De Carvalho I; Vantman D; Gabler F; Iñiguez G; Vega M
Fertil Steril; 2005 Jan; 83(1):110-5. PubMed ID: 15652895
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of low-dose human chorionic gonadotropin alone to complete controlled ovarian stimulation.
Filicori M; Cognigni GE; Gamberini E; Parmegiani L; Troilo E; Roset B
Fertil Steril; 2005 Aug; 84(2):394-401. PubMed ID: 16084880
[TBL] [Abstract][Full Text] [Related]
14. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial.
Calaf Alsina J; Ruiz Balda JA; Romeu Sarrió A; Caballero Fernández V; Cano Trigo I; Gómez Parga JL; González Batres C; Rodríguez Escudero FJ
BJOG; 2003 Dec; 110(12):1072-7. PubMed ID: 14664878
[TBL] [Abstract][Full Text] [Related]
15. A randomized comparison of ovulation induction and hormone profile between the aromatase inhibitor anastrozole and clomiphene citrate in women with infertility.
Wu HH; Wang NM; Cheng ML; Hsieh JN
Gynecol Endocrinol; 2007 Feb; 23(2):76-81. PubMed ID: 17454156
[TBL] [Abstract][Full Text] [Related]
16. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility.
Mitwally MF; Casper RF
Hum Reprod; 2003 Aug; 18(8):1588-97. PubMed ID: 12871867
[TBL] [Abstract][Full Text] [Related]
17. The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study.
Garcia-Velasco JA; Moreno L; Pacheco A; Guillén A; Duque L; Requena A; Pellicer A
Fertil Steril; 2005 Jul; 84(1):82-7. PubMed ID: 16009161
[TBL] [Abstract][Full Text] [Related]
18. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders.
Mitwally MF; Casper RF
Fertil Steril; 2002 Apr; 77(4):776-80. PubMed ID: 11937133
[TBL] [Abstract][Full Text] [Related]
19. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
20. Low-dose FSH stimulation in polycystic ovary syndrome: comparison of 3 FSH-preparations.
Strowitzki T; Seehaus D; Korell M; Hepp H
Exp Clin Endocrinol Diabetes; 1998; 106(5):435-9. PubMed ID: 9831312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
